PTC THERAPEUTICS INC (PTCT) Stock Analyst Ratings
NASDAQ:PTCT - Nasdaq - US69366J2006 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 75% to PTCT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 63.75. This target is 38.8% above the current price.
PTCT was analyzed by 22 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about PTCT.
In the previous month the buy percentage consensus was at a similar level.
PTCT was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-09 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-05-08 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-07 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-05-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-07 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-07 | Citigroup | Upgrade | Sell -> Neutral |
| 2025-04-22 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-31 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-11 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2025-03-07 | ScotiaBank | Initiate | Sector Perform |
| 2025-02-28 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-18 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-02-12 | Citigroup | Maintains | Sell -> Sell |
| 2025-02-03 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-01-15 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-12-13 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2024-12-04 | Goldman Sachs | Maintains | Sell -> Sell |
| 2024-12-04 | Citigroup | Maintains | Sell -> Sell |
| 2024-12-03 | UBS | Maintains | Buy -> Buy |
| 2024-12-03 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-12-03 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-27 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-26 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-14 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-11 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-08 | Baird | Maintains | Outperform -> Outperform |
| 2024-10-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |